Matches in SemOpenAlex for { <https://semopenalex.org/work/W2761736404> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2761736404 endingPage "263" @default.
- W2761736404 startingPage "261" @default.
- W2761736404 abstract "The adenosine A2A antagonist istradefylline has been used to treat Parkinson disease (PD) with symptoms of wearing-off since 2013 in Japan. Previous randomized controlled trials of istradefylline compared with placebo included PD patients experiencing an average daily OFF time of more than 2 hours. The purpose of this study is to assess the efficacy of 20 mg/d istradefylline in PD subjects experiencing an average daily OFF time of 3 hours or less.Fifteen patients were enrolled into this retrospective study. They received 20 mg/d istradefylline for 12 weeks. Changes in the Unified Parkinson's Disease Rating Scale part III scores in the ON state (ON-UPDRS-III) scores and daily OFF time were assessed at baseline and after 4, 8, and 12 weeks of administration of istradefylline.At baseline, all subjects had shorter daily OFF times, lower doses of L-DOPA and higher ON-UPDRS-III scores than those in previous randomized controlled trials. Twelve weeks of istradefylline significantly reduced ON-UPDRS-III scores (P < 0.001, Wilcoxon signed rank test). Eleven patients (73%) showed more than 50% reductions in ON-UPDRS-III scores. Improvement of ON-UPDRS-III was significantly correlated with baseline ON-UPDRS-III, and the mean ON-UPDRS-III score at end point was 12.1.Our result suggests that 20 mg/d istradefylline significantly improved motor functions in PD patients with mild wearing-off." @default.
- W2761736404 created "2017-10-20" @default.
- W2761736404 creator A5003493577 @default.
- W2761736404 creator A5007321577 @default.
- W2761736404 creator A5010654501 @default.
- W2761736404 creator A5037428535 @default.
- W2761736404 creator A5049271110 @default.
- W2761736404 date "2017-11-01" @default.
- W2761736404 modified "2023-09-27" @default.
- W2761736404 title "The Efficacy of Istradefylline for Treating Mild Wearing-Off in Parkinson Disease" @default.
- W2761736404 cites W1493115321 @default.
- W2761736404 cites W1969782593 @default.
- W2761736404 cites W2028285705 @default.
- W2761736404 cites W2038918555 @default.
- W2761736404 cites W2044590002 @default.
- W2761736404 cites W2068153776 @default.
- W2761736404 cites W2070912312 @default.
- W2761736404 cites W2111597060 @default.
- W2761736404 cites W2146659986 @default.
- W2761736404 doi "https://doi.org/10.1097/wnf.0000000000000249" @default.
- W2761736404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28976411" @default.
- W2761736404 hasPublicationYear "2017" @default.
- W2761736404 type Work @default.
- W2761736404 sameAs 2761736404 @default.
- W2761736404 citedByCount "9" @default.
- W2761736404 countsByYear W27617364042018 @default.
- W2761736404 countsByYear W27617364042019 @default.
- W2761736404 countsByYear W27617364042020 @default.
- W2761736404 countsByYear W27617364042021 @default.
- W2761736404 countsByYear W27617364042022 @default.
- W2761736404 countsByYear W27617364042023 @default.
- W2761736404 crossrefType "journal-article" @default.
- W2761736404 hasAuthorship W2761736404A5003493577 @default.
- W2761736404 hasAuthorship W2761736404A5007321577 @default.
- W2761736404 hasAuthorship W2761736404A5010654501 @default.
- W2761736404 hasAuthorship W2761736404A5037428535 @default.
- W2761736404 hasAuthorship W2761736404A5049271110 @default.
- W2761736404 hasBestOaLocation W27617364042 @default.
- W2761736404 hasConcept C126322002 @default.
- W2761736404 hasConcept C138496976 @default.
- W2761736404 hasConcept C142724271 @default.
- W2761736404 hasConcept C15744967 @default.
- W2761736404 hasConcept C168563851 @default.
- W2761736404 hasConcept C1862650 @default.
- W2761736404 hasConcept C204787440 @default.
- W2761736404 hasConcept C27081682 @default.
- W2761736404 hasConcept C2779134260 @default.
- W2761736404 hasConcept C2779734285 @default.
- W2761736404 hasConcept C42219234 @default.
- W2761736404 hasConcept C71924100 @default.
- W2761736404 hasConcept C83849319 @default.
- W2761736404 hasConceptScore W2761736404C126322002 @default.
- W2761736404 hasConceptScore W2761736404C138496976 @default.
- W2761736404 hasConceptScore W2761736404C142724271 @default.
- W2761736404 hasConceptScore W2761736404C15744967 @default.
- W2761736404 hasConceptScore W2761736404C168563851 @default.
- W2761736404 hasConceptScore W2761736404C1862650 @default.
- W2761736404 hasConceptScore W2761736404C204787440 @default.
- W2761736404 hasConceptScore W2761736404C27081682 @default.
- W2761736404 hasConceptScore W2761736404C2779134260 @default.
- W2761736404 hasConceptScore W2761736404C2779734285 @default.
- W2761736404 hasConceptScore W2761736404C42219234 @default.
- W2761736404 hasConceptScore W2761736404C71924100 @default.
- W2761736404 hasConceptScore W2761736404C83849319 @default.
- W2761736404 hasIssue "6" @default.
- W2761736404 hasLocation W27617364041 @default.
- W2761736404 hasLocation W27617364042 @default.
- W2761736404 hasLocation W27617364043 @default.
- W2761736404 hasOpenAccess W2761736404 @default.
- W2761736404 hasPrimaryLocation W27617364041 @default.
- W2761736404 hasRelatedWork W186530597 @default.
- W2761736404 hasRelatedWork W1920983895 @default.
- W2761736404 hasRelatedWork W2005343229 @default.
- W2761736404 hasRelatedWork W2059029335 @default.
- W2761736404 hasRelatedWork W2507295142 @default.
- W2761736404 hasRelatedWork W2549135832 @default.
- W2761736404 hasRelatedWork W2937993974 @default.
- W2761736404 hasRelatedWork W3159250744 @default.
- W2761736404 hasRelatedWork W4210801477 @default.
- W2761736404 hasRelatedWork W4233016836 @default.
- W2761736404 hasVolume "40" @default.
- W2761736404 isParatext "false" @default.
- W2761736404 isRetracted "false" @default.
- W2761736404 magId "2761736404" @default.
- W2761736404 workType "article" @default.